- Q2 2024 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 13, 2024$2.77 (+8.20%)Earnings
- Q1 2024 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$3.69 (+9.82%)Earnings
- Q4 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptMar 26, 2024$3.75 (-11.76%)Earnings
- Acumen Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptNov 13, 2023$2.03 (+6.84%)Earnings
- Acumen Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q2 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023$7Earnings
- Acumen Pharmaceuticals, Inc. - Special Call TranscriptJul 17, 2023
- Acumen Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023$5.73 (+18.14%)Earnings
- Q4 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptMar 27, 2023$4.21 (+7.40%)Earnings
- Q2 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 15, 2022$5.41 (+0.19%)Earnings
- Q1 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022Earnings
Acumen Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
&-
So good morning, everyone. I hope everyone has had a good conference so far. My name is Chris Tippett, Iâm an associate here on the healthcare investment banking team at JPMorgan. Today, it is my pleasure to introduce Acumen Pharmaceuticals. And without further ado, Iâd like to turn things over to the Chief Executive Officer and President, Dan OâConnell.
Thanks, Chris. Good morning, everyone. Itâs a pleasure to be here today, and we appreciate the invitation to present. And thanks to everyone here in the room, great to see some familiar faces, and for everyone on the webcast for taking the time to learn more about Acumen Pharmaceuticals.
Iâm Dan OâConnell, Iâm the President and CEO, as Chris indicated, and Iâm pleased to provide a bit of an overview of the company and some of the more recent data for our ACU193 program. I think youâre going to find, as we see the data, itâs very encouraging and bodes
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)